Propafenone
Product Images NDC 21695-814

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Propafenone (NDC 21695-814). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rebel Distributors Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (E4412a6a Ed4d 410d 8abb 86e1d7b72a3c 01)

Chemical structure diagram of propafenone hydrochloride, showing the arrangement of aromatic rings and functional groups including ester and amine moieties.*

FDA Label Image

Figure1 (E4412a6a Ed4d 410d 8abb 86e1d7b72a3c 02)

A Kaplan-Meier survival curve chart depicting the proportion of patients without an event over 300 days for Propafenone SR (Sustained Release) at 225 mg, 325 mg, and 425 mg doses, compared to placebo. The graph includes patient counts at risk over time and notes patient closeout beginning at day 273 (week 39).*

FDA Label Image

Propafenone HCl 325mg (E4412a6a Ed4d 410d 8abb 86e1d7b72a3c 03)

Label for Propafenone HCl 325 mg extended-release capsules, bottle of 60. The label indicates the capsules are orange opaque with black and white printing. Distributed by Physician Partner, manufactured by Par Pharmaceutical Companies Inc. The label includes lot and expiration date fields, and storage instructions to keep at controlled room temperature.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.